Deutsche Bank AG set a CHF 260 price target on Roche Holding Ltd. (VTX:ROG) in a research report report published on Friday morning. The firm currently has a neutral rating on the healthcare company’s stock.

Several other research firms have also recently commented on ROG. Sanford C. Bernstein set a CHF 284 price objective on Roche Holding and gave the company a buy rating in a research report on Tuesday, July 18th. Jefferies Group LLC set a CHF 305 price objective on Roche Holding and gave the company a buy rating in a research report on Saturday, May 20th. J P Morgan Chase & Co reaffirmed a buy rating on shares of Roche Holding in a research report on Wednesday, June 7th. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on Roche Holding and gave the company a buy rating in a research report on Friday, May 26th. Finally, BNP Paribas set a CHF 250 price objective on Roche Holding and gave the company a neutral rating in a research report on Tuesday, June 20th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the company. The stock presently has an average rating of Hold and an average price target of CHF 271.08.

Shares of Roche Holding (ROG) opened at 244.90 on Friday. Roche Holding has a 1-year low of CHK 218.30 and a 1-year high of CHK 273.00. The stock’s 50 day moving average price is CHK 246.64 and its 200-day moving average price is CHK 251.31. The company has a market capitalization of CHK 208.96 billion and a PE ratio of 20.69.

ILLEGAL ACTIVITY NOTICE: This news story was posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.watchlistnews.com/deutsche-bank-ag-analysts-give-roche-holding-ltd-rog-a-chf-260-price-target/1464644.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.